United Imaging Healthcare has raised 1 billion RMB in a Series A financing round to enhance AI technology integration in healthcare, supported by major investment firms.

Target Company Overview

Shanghai United Imaging Healthcare Co., Ltd. (referred to as 'United Imaging') has successfully completed a Series A financing round, raising a total of 1 billion RMB. The funding will significantly enhance the company's research and development efforts in areas such as medical large models and intelligent systems, advancing the innovation and application of AI technology in the healthcare sector.

United Imaging focuses on integrating advanced AI technology into critical aspects of the healthcare industry, including medical imaging analysis, intelligent diagnostic support, medical data management, disease prediction, high-end medical equipment innovation, and clinical research. Since its inception, the company has launched over 100 AI-powered medical products, with numerous offerings receiving Class II and III certifications from the National Medical Products Administration of China, as well as approvals from the U.S. FDA and EU CE certification, gaining wide recognition in both domestic and international markets.

Industry Overview in China

The healthcare industry in China is rapidly evolving, significantly driven by advancements in technology and an increasing focus on medical AI solutions. The deman

View Source

Similar Deals

启明创投 朗目医疗

2026

Series A Medical Devices & Implants China
Tencent, BGF T-Therapeutics

2025

Series A Bio Therapeutic Drugs China
Legend Capital, IDG BCIFlex

2025

Series A Bio Medical Devices China
启明创投 演生潮

2025

Series A Proprietary & Advanced Pharmaceuticals China

易方达私募基金管理有限公司 and 上国投资管

invested in

上海联影智能医疗科技有限公司

in 2025

in a Series A deal

Disclosed details

Transaction Size: $142M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert